Recent blog posts
RET Biologics Sequence Review Report 2026: Proto-oncogene tyrosine-protein kinase receptor Ret Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RET Biologics Sequence Review Report 2026: Proto-oncogene tyrosine-protein kinase receptor Ret Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RET protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTH2R Biologics Sequence Review Report 2026: Parathyroid hormone 2 receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTH2R Biologics Sequence Review Report 2026: Parathyroid hormone 2 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTH2R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
RAMP1 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RAMP1 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTGIR Biologics Sequence Review Report 2026: Prostacyclin receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTGIR Biologics Sequence Review Report 2026: Prostacyclin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGIR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTGER3 Biologics Sequence Review Report 2026: Prostaglandin E2 receptor EP3 subtype Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTGER3 Biologics Sequence Review Report 2026: Prostaglandin E2 receptor EP3 subtype Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGER3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTGFR Biologics Sequence Review Report 2026: Prostaglandin F2-alpha receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTGFR Biologics Sequence Review Report 2026: Prostaglandin F2-alpha receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGFR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTGER4 Biologics Sequence Review Report 2026: Prostaglandin E2 receptor EP4 subtype Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTGER4 Biologics Sequence Review Report 2026: Prostaglandin E2 receptor EP4 subtype Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGER4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PRLHR Biologics Sequence Review Report 2026: Prolactin-releasing peptide receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PRLHR Biologics Sequence Review Report 2026: Prolactin-releasing peptide receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PRLHR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTGER1 Biologics Sequence Review Report 2026: Prostaglandin E2 receptor EP1 subtype Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTGER1 Biologics Sequence Review Report 2026: Prostaglandin E2 receptor EP1 subtype Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGER1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTAFR Biologics Sequence Review Report 2026: Platelet-activating factor receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTAFR Biologics Sequence Review Report 2026: Platelet-activating factor receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTAFR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
OR1F1 Biologics Sequence Review Report 2026: Olfactory receptor 1F1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
OR1F1 Biologics Sequence Review Report 2026: Olfactory receptor 1F1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of OR1F1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
OXTR Biologics Sequence Review Report 2026: Oxytocin receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
OXTR Biologics Sequence Review Report 2026: Oxytocin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of OXTR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →